Cellectis (CLLS) Non Operating Income (2015 - 2026)

Cellectis (CLLS) recorded quarterly Non Operating Income of $7.4 million in Q1 2026, down 56.48% quarter-over-quarter from $17.1 million in Q4 2025, and up 288.68% on a YoY basis from $1.9 million in Q1 2025.

Cellectis (CLLS) Non Operating Income (2015 - 2026) Analysis & Trends

Cellectis' Non Operating Income history runs 12 years deep, the most recent figure standing at $7.4 million for Q1 2026.

  • In Q1 2026, Non Operating Income rose 288.68% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $3.0 million (up 139.88% YoY), while the FY2025 annual figure was -$34.9 million, down 253.29% from the prior year.
  • Non Operating Income was $7.4 million for Q1 2026 at Cellectis, down from $17.1 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $26.3 million in Q1 2024 to a low of -$20.0 million in Q4 2022.
  • Historically, Non Operating Income has averaged -$369882.4 across 5 years, with a median of -$3.9 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income sank 737.74% in 2022, then jumped 696.89% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$20.0 million in 2022, then soared by 38.81% to -$12.2 million in 2023, then surged by 240.17% to $17.1 million in 2024, then changed by 0.0% to $17.1 million in 2025, then slumped by 56.48% to $7.4 million in 2026.
  • The last three Non Operating Income figures came in at $7.4 million (Q1 2026), $17.1 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 7.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.45 Mn
Dec 31, 2025 17.12 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -14.15 Mn
Mar 31, 2025 -3.95 Mn
Dec 31, 2024 17.12 Mn
Sep 30, 2024 -12.35 Mn
Jun 30, 2024 -8.25 Mn
Mar 31, 2024 26.28 Mn
Dec 31, 2023 -12.21 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 -5.84 Mn
Mar 31, 2023 -4.40 Mn
Dec 31, 2022 -19.96 Mn
Sep 30, 2022 1.81 Mn
Jun 30, 2022 8.30 Mn
Mar 31, 2022 912,000.00
Dec 31, 2021 3.13 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 -4.13 Mn